Nature Biotechnology, Published online: 17 November 2025; doi:10.1038/s41587-025-02922-3
Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Red Queen Therapeutics is combating infectious diseases with peptide viral fusion inhibitors.
Nature Biotechnology, Published online: 17 November 2025; doi:10.1038/s41587-025-02922-3Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Red Queen Therapeutics is combating infectious diseases with peptide viral fusion inhibitors. Read More
